Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | PEPD | P12955 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | FDPS | P14324 | 1/20 | 0.39 |
| ▸ | PGK1 | P00558 | 1/20 | 0.33 |
| ▸ | PGK2 | P07205 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | PGD | P52209 | 1/20 | 0.31 |
| ▸ | SRC | P12931 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL345050 | 1.00 | — | — | |
| SCHEMBL9449862 | 1.00 | CA4 (0.50) | CA4PEPDBLMTDP1FDPS | |
| SCHEMBL285676 | 1.00 | CA4 (0.50) | CA4PEPDBLMTDP1FDPS | |
| SCHEMBL27564416 | 0.97 | PEPD (0.48) | CA4PEPDBLMTDP1FDPS | |
| SCHEMBL28640302 | 0.97 | PEPD (0.48) | CA4PEPDBLMTDP1FDPS | |
| Water SCHEMBL28561661 | 0.97 | PEPD (0.48) | CA4PEPDBLMTDP1FDPS | |
| SCHEMBL7775153 | 0.97 | CA4 (0.55) | CA4PEPDBLMTDP1FDPS | |
| Water SCHEMBL27495717 | 0.97 | PEPD (0.48) | CA4PEPDBLMTDP1FDPS | |
| Water SCHEMBL1864096 | 0.97 | PEPD (0.48) | CA4PEPDBLMTDP1FDPS | |
| SCHEMBL718181 | 0.97 | PEPD (0.48) | CA4PEPDBLMTDP1FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4608804-A1 | NOVEL CHLORHEXIDINE SALTS AND RELATED COMPOSITIONS AND METHODS | Colgate-Palmolive Company (US) | 2025-09-03 | — | — | EP | disclosed |
| US-20240199538-A1 | Novel Chlorhexidine Salts and Related Compositions and Methods | COLGATE-PALMOLIVE COMPANY | 2024-06-20 | — | — | US | disclosed |
| WO-2024123928-A1 | NOVEL CHLORHEXIDINE SALTS AND RELATED COMPOSITIONS AND METHODS | COLGATE-PALMOLIVE COMPANY (US) | 2024-06-13 | — | — | WO | disclosed |
| CN-1668214-A | Synergistic effect of diet and human interaction on the behavior of dogs | IAMS COMPANY (US) | 2005-09-14 | — | — | CN | disclosed |
| EP-1007520-B1 | 2-AMINOPYRIDINES CONTAINING FUSED RING SUBSTITUENTS AS NOS INHIBITORS | PFIZER PROD INC (US) | 2003-08-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240199538-A1 | Novel Chlorhexidine Salts and Related Compositions and Methods | HDHD5, LCT, CEL | CA4 1413/4885PEPD 2219/4885BLM 1832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.